vs
科睿唯安（CLVT）与PEGASYSTEMS INC（PEGA）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是PEGASYSTEMS INC的1.4倍（$617.0M vs $430.0M）。PEGASYSTEMS INC净利率更高（7.6% vs 0.5%，领先7.1%）。科睿唯安同比增速更快（-6.9% vs -9.6%）。PEGASYSTEMS INC自由现金流更多（$206.5M vs $89.2M）。过去两年PEGASYSTEMS INC的营收复合增速更高（10.7% vs -0.3%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
Pegasystems Inc.（简称Pega）是1983年成立的全球软件企业，总部位于美国马萨诸塞州沃尔瑟姆，1996年于纳斯达克上市，股票代码PEGA。公司主打低代码平台，面向企业客户提供工作流自动化、生成式AI驱动决策等相关解决方案。
CLVT vs PEGA — 直观对比
营收规模更大
CLVT
是对方的1.4倍
$430.0M
营收增速更快
CLVT
高出2.7%
-9.6%
净利率更高
PEGA
高出7.1%
0.5%
自由现金流更多
PEGA
多$117.3M
$89.2M
两年增速更快
PEGA
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $617.0M | $430.0M |
| 净利润 | $3.1M | $32.8M |
| 毛利率 | 66.8% | 75.2% |
| 营业利润率 | 6.7% | 8.6% |
| 净利率 | 0.5% | 7.6% |
| 营收同比 | -6.9% | -9.6% |
| 净利润同比 | 101.6% | -61.6% |
| 每股收益（稀释后） | $0.00 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTPEGA
| Q1 26 | — | $430.0M | ||
| Q4 25 | $617.0M | $504.3M | ||
| Q3 25 | $623.1M | $381.4M | ||
| Q2 25 | $621.4M | $384.5M | ||
| Q1 25 | $593.7M | $475.6M | ||
| Q4 24 | $663.0M | $490.8M | ||
| Q3 24 | $622.2M | $325.1M | ||
| Q2 24 | $650.3M | $351.2M |
净利润CLVTPEGA
| Q1 26 | — | $32.8M | ||
| Q4 25 | $3.1M | $234.6M | ||
| Q3 25 | $-28.3M | $43.4M | ||
| Q2 25 | $-72.0M | $30.1M | ||
| Q1 25 | $-103.9M | $85.4M | ||
| Q4 24 | $-191.8M | $119.1M | ||
| Q3 24 | $-65.6M | $-14.4M | ||
| Q2 24 | $-304.3M | $6.6M |
毛利率CLVTPEGA
| Q1 26 | — | 75.2% | ||
| Q4 25 | 66.8% | 79.5% | ||
| Q3 25 | 65.0% | 72.2% | ||
| Q2 25 | 67.2% | 71.5% | ||
| Q1 25 | 65.1% | 78.5% | ||
| Q4 24 | 65.7% | 79.1% | ||
| Q3 24 | 66.2% | 70.2% | ||
| Q2 24 | 67.2% | 72.4% |
营业利润率CLVTPEGA
| Q1 26 | — | 8.6% | ||
| Q4 25 | 6.7% | 20.7% | ||
| Q3 25 | 7.1% | 3.8% | ||
| Q2 25 | 1.1% | 4.5% | ||
| Q1 25 | -3.5% | 26.7% | ||
| Q4 24 | -9.4% | 29.1% | ||
| Q3 24 | 3.5% | -3.6% | ||
| Q2 24 | -36.9% | 3.7% |
净利率CLVTPEGA
| Q1 26 | — | 7.6% | ||
| Q4 25 | 0.5% | 46.5% | ||
| Q3 25 | -4.5% | 11.4% | ||
| Q2 25 | -11.6% | 7.8% | ||
| Q1 25 | -17.5% | 18.0% | ||
| Q4 24 | -28.9% | 24.3% | ||
| Q3 24 | -10.5% | -4.4% | ||
| Q2 24 | -46.8% | 1.9% |
每股收益（稀释后）CLVTPEGA
| Q1 26 | — | $0.18 | ||
| Q4 25 | $0.00 | $0.81 | ||
| Q3 25 | $-0.04 | $0.24 | ||
| Q2 25 | $-0.11 | $0.17 | ||
| Q1 25 | $-0.15 | $0.91 | ||
| Q4 24 | $-0.27 | $1.35 | ||
| Q3 24 | $-0.09 | $-0.17 | ||
| Q2 24 | $-0.46 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | $270.0M |
| 总债务越低越好 | $4.3B | — |
| 股东权益账面价值 | $4.8B | $705.9M |
| 总资产 | $11.1B | $1.6B |
| 负债/权益比越低杠杆越低 | 0.89× | — |
8季度趋势，按日历期对齐
现金及短期投资CLVTPEGA
| Q1 26 | — | $270.0M | ||
| Q4 25 | $329.2M | $425.8M | ||
| Q3 25 | $318.7M | $351.4M | ||
| Q2 25 | $362.6M | $411.6M | ||
| Q1 25 | $354.0M | $371.7M | ||
| Q4 24 | $295.2M | $740.0M | ||
| Q3 24 | $388.5M | $703.0M | ||
| Q2 24 | $376.4M | $665.1M |
总债务CLVTPEGA
| Q1 26 | — | — | ||
| Q4 25 | $4.3B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — |
股东权益CLVTPEGA
| Q1 26 | — | $705.9M | ||
| Q4 25 | $4.8B | $787.4M | ||
| Q3 25 | $4.9B | $596.8M | ||
| Q2 25 | $5.0B | $624.5M | ||
| Q1 25 | $5.0B | $611.3M | ||
| Q4 24 | $5.1B | $585.5M | ||
| Q3 24 | $5.5B | $473.0M | ||
| Q2 24 | $5.6B | $435.4M |
总资产CLVTPEGA
| Q1 26 | — | $1.6B | ||
| Q4 25 | $11.1B | $1.6B | ||
| Q3 25 | $11.2B | $1.3B | ||
| Q2 25 | $11.4B | $1.3B | ||
| Q1 25 | $11.5B | $1.3B | ||
| Q4 24 | $11.5B | $1.8B | ||
| Q3 24 | $12.0B | $1.6B | ||
| Q2 24 | $12.1B | $1.5B |
负债/权益比CLVTPEGA
| Q1 26 | — | — | ||
| Q4 25 | 0.89× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $159.9M | — |
| 自由现金流经营现金流 - 资本支出 | $89.2M | $206.5M |
| 自由现金流率自由现金流/营收 | 14.5% | 48.0% |
| 资本支出强度资本支出/营收 | 11.5% | — |
| 现金转化率经营现金流/净利润 | 51.58× | — |
| 过去12个月自由现金流最近4个季度 | $365.3M | $494.9M |
8季度趋势，按日历期对齐
经营现金流CLVTPEGA
| Q1 26 | — | — | ||
| Q4 25 | $159.9M | $158.4M | ||
| Q3 25 | $181.1M | $56.3M | ||
| Q2 25 | $116.3M | $86.3M | ||
| Q1 25 | $171.2M | $204.2M | ||
| Q4 24 | $141.3M | $95.2M | ||
| Q3 24 | $202.9M | $30.5M | ||
| Q2 24 | $126.2M | $40.1M |
自由现金流CLVTPEGA
| Q1 26 | — | $206.5M | ||
| Q4 25 | $89.2M | $152.4M | ||
| Q3 25 | $115.5M | $51.8M | ||
| Q2 25 | $50.3M | $84.1M | ||
| Q1 25 | $110.3M | $202.3M | ||
| Q4 24 | $59.1M | $92.4M | ||
| Q3 24 | $126.3M | $27.4M | ||
| Q2 24 | $60.3M | $38.8M |
自由现金流率CLVTPEGA
| Q1 26 | — | 48.0% | ||
| Q4 25 | 14.5% | 30.2% | ||
| Q3 25 | 18.5% | 13.6% | ||
| Q2 25 | 8.1% | 21.9% | ||
| Q1 25 | 18.6% | 42.5% | ||
| Q4 24 | 8.9% | 18.8% | ||
| Q3 24 | 20.3% | 8.4% | ||
| Q2 24 | 9.3% | 11.1% |
资本支出强度CLVTPEGA
| Q1 26 | — | — | ||
| Q4 25 | 11.5% | 1.2% | ||
| Q3 25 | 10.5% | 1.2% | ||
| Q2 25 | 10.6% | 0.6% | ||
| Q1 25 | 10.3% | 0.4% | ||
| Q4 24 | 12.4% | 0.6% | ||
| Q3 24 | 12.3% | 0.9% | ||
| Q2 24 | 10.1% | 0.4% |
现金转化率CLVTPEGA
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | 0.68× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | — | 2.87× | ||
| Q1 25 | — | 2.39× | ||
| Q4 24 | — | 0.80× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 6.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
PEGA
| Pega Cloud | $205.0M | 48% |
| Subscription license | $94.9M | 22% |
| Maintenance | $75.3M | 18% |
| Consulting | $54.8M | 13% |
